Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Progress and prospects of the EORTC

Prof Bertrand Tombal - Université catholique de Louvain, Brussels, Belgium
Progress and prospects of the EORTC ( Prof Bertrand Tombal - Université catholique de Louvain, Brussels, Belgium )
21 Mar 2019

Gynaecological cancer: Where are we now?

Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands
Gynaecological cancer: Where are we now? ( Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands )
21 Mar 2019

Assessing quality of life in clinical trials

Prof Mogens Grønvold - University of Copenhagen, Copenhagen, Denmark
Assessing quality of life in clinical trials ( Prof Mogens Grønvold - University of Copenhagen, Copenhagen, Denmark )
21 Mar 2019

EORTC infrastructure: The road ahead

Dr Vassilis Golfinopoulos - European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium
EORTC infrastructure: The road ahead ( Dr Vassilis Golfinopoulos - European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium )
21 Mar 2019

Innovating India: Rural healthcare in Salboni

Innovating India: Rural healthcare in Salboni (  )
28 Feb 2019

Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice

Prof Josep Llovet, Dr Richard Finn
Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice ( Prof Josep Llovet, Dr Richard Finn )
25 Feb 2019

Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma

Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK
Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma ( Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK )
19 Feb 2019

KEYNOTE-427 cohort B: First-line pembrolizumab monotherapy for advanced non-clear cell renal cell carcinoma

Prof David McDermott - Beth Israel Deaconess Medical Center, Boston, USA
KEYNOTE-427 cohort B: First-line pembrolizumab monotherapy for advanced non-clear cell renal cell carcinoma ( Prof David McDermott - Beth Israel Deaconess Medical Center, Boston, USA )
19 Feb 2019

Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of metastatic castration-resistant prostate cancer

Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA
Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of metastatic castration-resistant prostate cancer ( Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA )
19 Feb 2019

Updates from the BCON trial: Longterm outcomes of hypoxia modification in bladder preservation

Dr Yee Pei Song - The Christie NHS Foundation Trust, Manchester, UK
Updates from the BCON trial: Longterm outcomes of hypoxia modification in bladder preservation ( Dr Yee Pei Song - The Christie NHS Foundation Trust, Manchester, UK )
18 Feb 2019

Penile squamous cell carcinoma is genomically similar to other HPV-driven tumours

Dr Jad Chahoud - MD Anderson Cancer Center, Houston, USA
Penile squamous cell carcinoma is genomically similar to other HPV-driven tumours ( Dr Jad Chahoud - MD Anderson Cancer Center, Houston, USA )
18 Feb 2019

CB-839 in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer

Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA
CB-839 in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer ( Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA )
18 Feb 2019